Bronchoalveolar lavage (BAL) has proved valuable in the diagnosis of pulmonary complications in immunosuppressed patients. We evaluated the diagnostic yield of BAL in pulmonary complications in bone marrow transplantation (BMT) recipients. We reviewed sequentially the records of 89 patients during an 18-month period. BAL was diagnostic in 42 patients (47%). The most common pulmonary complication diagnosed by BAL was diffuse alveolar hemorrhage (n ‫؍‬ 15); followed by bacterial pneumonia (n ‫؍‬ 10), respiratory syncytial virus (n ‫؍‬ 8), aspergillosis (n ‫؍‬ 6), Pneumocystis carinii pneumonia (n ‫؍‬ 5), cytomegalovirus (CMV) (n ‫؍‬ 4), and others (n ‫؍‬ 4). The final diagnoses in the BAL nondiagnostic group were: bacterial pneumonia (n ‫؍‬ 6), CMV (n ‫؍‬ 6), idiopathic pneumonia syndrome (n ‫؍‬ 5), cancer recurrence (n ‫؍‬ 4), cardiogenic pulmonary edema (n ‫؍‬ 4), and others (n ‫؍‬ 9). We conclude that BAL is a useful diagnostic tool in BMT-related pulmonary complications. Bone Marrow Transplantation (2000) 25, 975-979. Keywords: bone marrow transplantation; bronchoalveolar lavage; bronchoscopy; lung diseases; fiber optics Pulmonary complications occur in recipients of bone marrow transplantation (BMT) due to toxicity of the conditioning regimen, and to infections related to the post-transplant immunodeficiency and graft-versus-host disease.
Pulmonary complications occur in recipients of bone marrow transplantation (BMT) due to toxicity of the conditioning regimen, and to infections related to the post-transplant immunodeficiency and graft-versus-host disease. [1] [2] [3] [4] These pulmonary complications constitute the major cause of morbidity and mortality in immunosuppressed patients. [5] [6] [7] It is generally accepted that the earlier the etiology is recognized the better the outcome. 2, 8 Fiberoptic bronchoscopy (FOB) is the most frequently used tool in the diagnosis of pulmonary complications in BMT patients. 6, [9] [10] [11] [12] [13] [14] [15] [16] However, it is frequently not possible to obtain a biopsy because of concomitant thrombocytopenia. 3 Then, FOB is limited to bronchoalveolar lavage (BAL). 17, 18 Several studies have established a diagnostic yield from 20% to more than 65%, and complication rates from 0 to 27%. 1, 3, 6, [8] [9] [10] 12, 16, 18, 19 We reviewed results of FOB with BAL in 89 BMT patients in order to assess the diagnostic 
Patients and methods
We sequentially reviewed the records of 89 patients at MD Anderson who underwent FOB with BAL as part of their diagnostic work-up for pulmonary complications following BMT (either allogeneic or autologous) during an 18 month period.
The main indication for BAL was the development of new pulmonary radiographic infiltrates. FOB was performed using a conventional technique. Because our patients frequently have some degree of thrombocytopenia, the oral route was preferred due to its lower risk of bleeding compared with the nasal route. The fiberoptic bronchoscope was wedged into a subsegmental bronchus, and four to six 20 ml aliquots of sterile normal saline were instilled and retrieved using a syringe. BAL fluid was then sent for cytologic and microbiologic examinations that included: gram stain and culture, acid-fast bacilli stain and culture, fungal stain and culture, methenamine silver stain, direct fluorescence antibody for legionella, Gomori's methenamine-silver staining for Pneumocystis carinii, mycoplasma culture, viral studies, respiratory syncytial virus (RSV) rapid antigen, cytomegalovirus (CMV) shell vial method (detects virus in fluids), cytopathologic studies, including Papanicolau and hemosiderin staining, and the following cell lines for viral cultures: skin fibroblast (Herpes virus and CMV), Rhesus monkey kidney (respiratory virus), and HEP 2 (adenovirus and RSV).
Final diagnoses were established based on microbiologic, cytologic and/or histopathologic proof of disease and confirmed based on clinicoradiologic evidence and autopsy results, if available. Organisms that are unlikely to cause nosocomial pneumonia such as coagulase-negative staphylococci were excluded following the criteria established by the American Thoracic Society. 20 BAL was considered positive for bacterial pneumonia when an organism was isolated by culture; for aspergillosis, when hyphae was identified on the smear or fungal cultures were positive; for Pneumocystis carinii pneumonia (PCP) when the stain was positive, CMV/RSV when rapid antigen was detected or cytopathic effect was observed.
For the diagnosis of bacterial pneumonia, we followed the criteria established by the American Thoracic Society. 20 Bacterial pneumonia was diagnosed if any organism was recovered or if lobar infiltrates disappeared with antibiotic therapy, the clinical criteria of fever, purulent sputum or leukocytosis were not applicable in our immunocompromised patients. We did not differentiate bacterial colonization from bacterial infection because once any bacterium grows, it is considered an infection due to the nature of our high-risk immunodeficiency patients. We did not perform semi-quantitative cultures.
Diffuse alveolar hemorrhage was diagnosed when sequential BAL fluid instillation became progressively bloodier upon aspiration, 21 and cancer recurrence when malignant cells were identified in the BAL. Bronchiolitis obliterans organizing pneumonia (BOOP) was only diagnosed upon microscopic tissue examination by identifying polypoid masses of granulation tissue filling and obstructing the bronchioles and alveolar ducts. 22 Idiopathic pneumonia syndrome (IPS) was diagnosed if there was evidence of widespread alveolar injury-multilobar infiltrates on chest X-ray or CT scan, with symptoms and signs of pneumonia and evidence of abnormal physiology, together with absence of active lower respiratory tract infection documented by negative BAL, lung biopsy, or autopsy, including stains, cultures or immunofluorescence for bacteria, fungi, and viruses, and cytology for viral inclusions and Pneumocystis carinii. [23] [24] [25] In summary, IPS was diagnosed in patients in whom no microbiological etiology could be found in conjunction with findings of non-specific interstitial pneumonitis upon histological examination.
We conducted a cross-sectional study. Two-by-two contingency tables were analyzed with chi-square statistical analysis with Yates correction for continuity. 26 All P values of less than 0.05 were considered to indicate statistical significance.
Results
During an 18 month period, 375 BMTs were performed. The medical records of 89 patients with pulmonary complications following BMT who underwent FOB with BAL were reviewed, all of them developed pulmonary infiltrates on chest X-ray. Forty-four patients had undergone allogeneic BMT and 45 autologous BMT. All patients had been evaluated by our Pulmonary/Critical Care Medicine consultation service. Selected patients underwent the following: transbronchial lung biopsy (TBLB) (n ϭ 1), fine needle aspiration (FNA) (n ϭ 1), and open lung biopsy (OLB) (n ϭ 4). One hundred and twenty-four BAL were performed on 89 patients: 55 patients had one bronchoscopy, 33 had two, and only one had three. The same BAL could yield to more than one diagnosis.
Pulmonary complications were accurately diagnosed by BAL in 42% of bronchoscopies. When this group was divided into allogeneic and autologous BMT, both subgroups had a similar diagnostic yield: 45% in the allogeneic BMT patients and 39% in the autologous BMT patients.
The most common diagnosis made by BAL was the infectious etiology of pneumonia, due to bacterial, fungi, virus, or parasites (66% of all diagnostic BAL). Among the causes identified by BAL, bacterial pneumonia was the disease most frequently diagnosed, predominantly occurring in the earlier phases after BMT. Pneumonia was seen predominantly in the allogeneic BMT patients, whereas RSV pneumonitis, the second most common infectious etiology, was more frequently found in the autologous group ( 2 ϭ 4.43, P Ͻ 0.05). All of our patients had only one episode of pneumonia. Diffuse alveolar hemorrhage (DAH) was by far the most frequently diagnosed non-infectious condition (Table 1) . DAH was missed in only two cases (diagnosed by autopsy), giving a high diagnostic yield of BAL for this condition (88%). On the noninfectious side, we also noticed that during the first 30 days after BMT, BAL had more positive findings. This could be related to the high number of DAH and the high diagnostic yield of this condition.
When BAL was non-diagnostic, bacterial pneumonia and CMV pneumonitis were the infectious etiologies most frequently found by other means (TBLB, FNA, OLB, and/or autopsies). In the noninfectious etiology group, congestive heart failure (CHF) with pulmonary edema, cancer recurrence, and IPS were the conditions most commonly missed by BAL (Table 2) . A definitive final diagnosis could not be established in 26 of the 72 non-diagnostic BAL cases. Table 3 shows the final etiological diagnoses, excluding CHF/pulmonary edema. Pneumocystis carinii pneumonia was diagnosed in all cases and RSV in almost all.
Discussion
Pulmonary complications remain a major obstacle to the success of bone marrow transplantation. Bronchoalveolar lavage is the most commonly used diagnostic tool in BMT patients who develop pulmonary complications because of its low complication rate in this fragile, frequently thrombocytopenic population. 18 During the study, our patients had no complications other than a transient insignificant decline in gas exchange.
Our study revealed a relatively high diagnostic yield with BAL (47%). The value of BAL is based mainly on its ability to diagnose diffuse pulmonary hemorrhage and infectious complications. Although the incidence of PCP was low in comparison with other series, BAL was a very useful technique for establishing this diagnosis. 3, 5, 9, 17, 27 Bacterial pneumonia predominantly occurred in neutropenic patients 1,2,28,29 (Ͻ30 days after BMT). We found a relatively high incidence of RSV infection, 5, 19, 29 an increasingly recognized infectious complication that occurs in the early post-transplant period (first 100 days). This infection carries a high mortality, particularly when there is a delay in diagnosis and treatment. [30] [31] [32] In RSV, the BAL findings were quite high (eight of nine) due to a seasonal pattern that paralleled the flu season. CMV infection had the poorest BAL diagnostic yield (four of 10). 12 We did not find any cases of legionella infection, as reported by other groups.
12,15,17 However, our low incidence of PCP and CMV could be explained by the fact that our population was receiving prophylaxis.
The main limitations of BAL were in the noninfectious etiology group, in which BAL was unable to diagnose IPS, BOOP, and drug-induced pulmonary toxicity, the last of which was not documented in this series. 17 These disorders 977 Table 1 Diagnostic bronchoalveolar lavage cannot be readily diagnosed based upon cytologic findings. We found that IPS occurred at any time following BMT, cardiogenic pulmonary edema and DAH occurred mainly early, and BOOP occurred in the late phase. These findings correlate with other reports. 2, 6 BAL is very useful in the recognition of DAH, a disease that carries a very high mortality but which can be effectively treated. 12, 33, 34 In Table 4 , we have included the results of previous studies of a similar design, but the first five were mostly directed towards infectious etiologies. 8, 11, 16, 19, 29 In the remaining three (including our study), Glazer et al 6 reported the best diagnostic yield (67%), with a BAL/patient ratio of 1.27, whereas White et al 12 had a diagnostic yield of 31% with a BAL/patient ratio of 1.3; and our study had a diagnostic yield of 42% and a BAL/patient ratio of 1.47. In our study all our repeat BALs were negative, thereby decreasing our diagnostic yield.
Bone Marrow Transplantation
We conclude that bronchoalveolar lavage is a useful procedure for the diagnosis of pulmonary complications, particularly infections and pulmonary hemorrhage following BMT. It was most accurate for the diagnosis of PCP, RSV, bacterial infection, and DAH and less useful for the diagnosis of CMV and cancer recurrence.
Bronchoalveolar lavage has proved to be a valuable diagnostic tool in immunosuppressed BMT patients. With further refinements on the horizon, such as rapid detection of aspergillus and other infections via polymerase chain reaction, the diagnostic yield of BAL may improve, and will probably remain a valuable diagnostic tool for years to come. a Same patient could have more than one BAL, either (Ϫ) or (ϩ). 
